Abstract

Cardiac rehabilitation (CR) is an essential program aimed at improving the physical and psychological well being of patients recovering from cardiovascular events. Psychotropic medications, which include antidepressants, anxiolytics, and antipsychotics, play a significant role in managing mental health disorders that may accompany cardiovascular diseases. This article explores the intersection of psychotropic medications and cardiac rehabilitation, examining their effects on rehabilitation outcomes, adherence to treatment, and overall cardiovascular health. Understanding the implications of these medications can enhance the efficacy of cardiac rehabilitation programs and improve patient outcomes.